Form 4: Teradyne Director Peter Herweck Acquires Shares Through Deferred Compensation
SEC Form 4
Director Peter Herweck acquired 320 shares of Teradyne common stock through a deferral of quarterly cash compensation into Deferred Stock Units (DSUs).
Summary
- On March 27, 2025, Peter Herweck, a director of Teradyne, Inc., acquired 320 shares of common stock.
- The acquisition was a result of deferring quarterly cash compensation into Deferred Stock Units (DSUs).
- The price per share was $0.
- Following the transaction, Herweck directly owns 11,711 shares of Teradyne common stock.
- DSUs are settled one-for-one in Common Stock generally within ninety days of the date as of which a non-employee director no longer serves in such capacity.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction indicating director alignment with company interests, but it's not a major event.
Positives
- The acquisition of shares by a director may signal confidence in the company's future performance.
Future Outlook
The DSUs will be settled one-for-one in common stock generally within ninety days of the date as of which a non-employee director no longer serves in such capacity.
Industry Context
Director share acquisitions are common and often viewed positively, reflecting alignment between management and shareholder interests. This is a standard practice for compensating board members.
Comparison to Industry Standards
- Director compensation through stock and deferred stock units is a common practice among publicly traded companies, particularly in the technology sector.
- Companies like Texas Instruments and Analog Devices also utilize similar compensation strategies to align director interests with shareholder value.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 03/27/2025 | Date of transaction: Peter Herweck acquired 320 shares of Teradyne common stock. |
| 03/31/2025 | Date of signature for the Form 4 filing. |
Keywords
Teradyne, Director, Herweck, Form 4, Beneficial Ownership, Deferred Stock Units, DSUs, Compensation, Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.